ArticleNeuro-oncology advances

HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal disease.

Jie Wei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.